NEW YORK (GenomeWeb News) — Bioinformatics shop CLC Bio has received an undisclosed amount of new financial backing from several new private Danish investors, the company said today.
 
The new backers include Peter Bogild, Tom Nordin, and Thomas Bruno, who have a combined capital base of $200 million, the company said.
 
CLC Bio will use the funding to continue developing software for next-generation sequencing and to continue to enhance its current product line, company CEO Thomas Knudsen said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more. 

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.